In contrast, the two subcategories of HER2-positive carcinomas: HER2 2+ WA and 3+ carcinomas, as well as the subgroups of H2L carcinomas HER2 1+, 2+NA, and DE carcinomas, had very different expression levels. This evidence concerns the gene ERBB2 and carcinoma.